Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology.

Eilertsen M, Pettersen I, Andersen S, Martinez I, Donnem T, Busund LT, Bremnes RM.

Anticancer Res. 2012 Nov;32(11):4729-36.

PMID:
23155236
2.

Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.

Bircan A, Bircan S, Kapucuoglu N, Songur N, Ozturk O, Akkaya A.

Pathol Oncol Res. 2010 Dec;16(4):553-61. doi: 10.1007/s12253-010-9259-5. Epub 2010 Mar 28.

PMID:
20349288
3.

Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.

Ozbudak IH, Ozbilim G, Kucukosmanoglu I, Dertsiz L, Demircan A.

Int J Surg Pathol. 2009 Oct;17(5):390-5. doi: 10.1177/1066896908323506. Epub 2008 Oct 10.

PMID:
18849317
4.

[Expression and prognostic value of VEGF-C and lymphangeogenesis in lung adenocarcinoma and squamous cell carcinoma].

Dai X, Wang W, Shen-Tu Y, Zhang J.

Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):774-9. doi: 10.3779/j.issn.1009-3419.2011.10.02. Chinese.

5.

Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.

Seto T, Higashiyama M, Funai H, Imamura F, Uematsu K, Seki N, Eguchi K, Yamanaka T, Ichinose Y.

Lung Cancer. 2006 Jul;53(1):91-6. Epub 2006 May 11.

PMID:
16697074
6.

Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.

Bonnesen B, Pappot H, Holmstav J, Skov BG.

Lung Cancer. 2009 Dec;66(3):314-8. doi: 10.1016/j.lungcan.2009.02.013. Epub 2009 Mar 25.

PMID:
19324448
7.

Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.

Zhu YM, Azahri NS, Yu DC, Woll PJ.

BMC Cancer. 2008 Jul 31;8:218. doi: 10.1186/1471-2407-8-218.

8.

Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer.

Stefanou D, Goussia AC, Arkoumani E, Agnantis NJ.

Anticancer Res. 2003 Nov-Dec;23(6C):4715-20.

PMID:
14981918
9.

The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.

Wang J, Zhao W, Guo Y, Zhang B, Xie Q, Xiang D, Gao J, Wang B, Chen Z.

Oncology. 2009;76(6):420-9. doi: 10.1159/000216837. Epub 2009 May 5.

PMID:
19420963
10.

[Expression and significance of Elf-1 and vascular endothelial growth factor in non-small cell lung cancer].

Yang DX, Han YC, Liu LY, Yu N, Wang X, Shi Y.

Ai Zheng. 2009 Jul;28(7):762-7. Chinese.

PMID:
19624906
11.

Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers.

Takahama M, Tsutsumi M, Tsujiuchi T, Kido A, Okajima E, Nezu K, Tojo T, Kushibe K, Kitamura S, Konishi Y.

Jpn J Clin Oncol. 1998 Mar;28(3):176-81.

PMID:
9614439
12.
13.

[Expression of HDGF and its implication in stage I non-small cell lung cancer].

Zhou SJ, Xu SF, Zhang HQ, Liu ZD.

Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):927-30. Chinese.

PMID:
18478933
14.
15.

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.

O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL.

Br J Cancer. 2000 Apr;82(8):1427-32.

16.

Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.

Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL.

Cancer Res. 2000 Jun 1;60(11):3088-95.

17.

Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.

Nakashima T, Huang CL, Liu D, Kameyama K, Masuya D, Ueno M, Haba R, Yokomise H.

Med Sci Monit. 2004 Jun;10(6):BR157-65. Epub 2004 Jun 1.

PMID:
15173661
18.
19.

Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.

Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ.

Int J Oncol. 2008 Mar;32(3):585-92.

PMID:
18292935
20.

Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.

Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T.

Eur J Cardiothorac Surg. 2004 Mar;25(3):443-8.

PMID:
15019676

Supplemental Content

Support Center